UCLA HIV prevention and treatment clinical trials program
UCLA AIDS Prevention and Treatment Clinical Trials Unit
UCLA runs clinical trials testing new HIV treatments, vaccines, and prevention methods for adults living with or at risk for HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11237561 on NIH RePORTER |
What this research studies
At this UCLA program I could join trials testing new HIV medicines, vaccines, or prevention strategies through clinics in Los Angeles and partner sites in Brazil and Argentina. The team includes HIV doctors, researchers, and nurses who design studies, enroll participants, perform regular visits, collect blood and other samples, and monitor safety and side effects. Some trials offer experimental pills, injections, or vaccines and may compare them to standard treatments or provide prevention visits and counseling. Participation requirements, visit schedules, and possible risks vary by trial and would be explained before joining.
Who could benefit from this research
Good fit: Adults (typically 21 and older) living with HIV or at high risk of acquiring HIV who meet the specific trial's health and medication criteria are the usual candidates.
Not a fit: Children, people who can't travel to the study sites, or those who don't meet trial-specific health or medication rules are unlikely to benefit directly from these trials.
Why it matters
Potential benefit: Joining may give access to new HIV treatments or prevention options and close medical follow-up that could improve your care.
How similar studies have performed: Many past clinical trials at academic centers have produced the antiretroviral drugs and prevention tools (like PrEP) that transformed HIV care, although vaccines remain a challenging area.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Landovitz, Raphael J — University of California Los Angeles
- Study coordinator: Landovitz, Raphael J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.